Biopharma Group is a global CDMO specialising in both liquid and freeze-dried technologies. With over 30 years of experience in the pharmaceutical and biotech sectors, we have supported companies worldwide in characterising materials, scaling up processes, troubleshooting products, producing freeze-dried materials under GMP and non-GMP conditions, developing reliable cycles, and more. Our expertise spans a wide range of product types, including small molecules, large molecules, recombinant proteins, vaccines, ADCs, cells, and microorganisms, making us well-equipped to meet your specific needs.

Types of drug manufactured:

Small Molecule;Biologics;Cell & Gene Therapy;Medical Devices

CDMO services:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Analytical Development

No. of manufacturing facilities:

1

High potent product capabilities:

OEB 3;OEB 4-5;OEB >5

Facilities location:

Europe;North America

Regulatory approvals:

ISO;GMP

Manufacturing technologies:

Cartridges;Liquids;Lyophilized amps/vials;Semi-solids;Solids;Sterile Vials

Current capacity:

We have capacity for new customers for both R&D and GMP work. We have capacity to support formulation development, liquid fill finish and freeze drying projects.

Biopharma Group is well-equipped to meet the varied needs of its clients within the pharmaceutical industry. For more information, please visit biopharma.co.uk.